Logo image
Sevelamer Does Not Decrease Lipopolysaccharide or Soluble CD14 Levels But Decreases Soluble Tissue Factor, Low-Density Lipoprotein (LDL) Cholesterol, and Oxidized LDL Cholesterol Levels in Individuals With Untreated HIV Infection
Journal article   Open access   Peer reviewed

Sevelamer Does Not Decrease Lipopolysaccharide or Soluble CD14 Levels But Decreases Soluble Tissue Factor, Low-Density Lipoprotein (LDL) Cholesterol, and Oxidized LDL Cholesterol Levels in Individuals With Untreated HIV Infection

Netanya G. Sandler, Xinyan Zhang, Ronald J. Bosch, Nicholas T. Funderburg, Andrew I. Choi, Janet K. Robinson, Derek M. Fine, Robert W. Coombs, Jeffrey M. Jacobson, Alan L. Landay, …
The Journal of infectious diseases, v 210(10), pp 1549-1554
15 Nov 2014
PMID: 24864123
url
https://academic.oup.com/jid/article-pdf/210/10/1549/18070500/jiu305.pdfView
Published, Version of Record (VoR) Open
url
https://doi.org/10.1093/infdis/jiu305View
Published, Version of Record (VoR) Open

Abstract

Immunology Infectious Diseases Life Sciences & Biomedicine Microbiology Science & Technology
Abnormal levels of inflammation are associated with cardiovascular disease and mortality in human immunodeficiency virus (HIV)-infected patients. Microbial translocation, which may cause inflammation, is decreased by sevelamer in patients undergoing hemodialysis. In this single-arm study, we evaluated the effects of 8 weeks of sevelamer therapy on 36 HIV-infected subjects who were not receiving antiretroviral therapy. Sevelamer did not significantly change markers of microbial translocation, inflammation, or T-cell activation. During sevelamer treatment, however, levels of soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol decreased significantly, whereas D-dimer levels increased. Thus, in this study population, sevelamer did not reduce microbial translocation but may have yielded cardiovascular benefits.

Metrics

7 Record Views
75 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Immunology
Infectious Diseases
Microbiology
Logo image